Cargando…

A randomized placebo-controlled trial of paroxetine for the management of anxiety in chronic obstructive pulmonary disease (PAC Study)

BACKGROUND: Despite the high prevalence of anxiety in COPD patients and its impact on quality of life, evidence to support the effectiveness of various anxiety treatment options is insufficient, leading to the need for further research in this field. AIM: The aim of this study was to assess the effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usmani, Zafar A, Carson-Chahhoud, Kristin V, Esterman, Adrian J, Smith, Brian J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027696/ https://www.ncbi.nlm.nih.gov/pubmed/29983572 http://dx.doi.org/10.2147/JMDH.S166022

Ejemplares similares

Efficacy of cognitive behavioral therapy with paroxetine and paroxetine only for social anxiety disorder: A behavioral, placebo-controlled study
por: Samantray, Narendranath, et al.
Publicado: (2019)

Short-acting bronchodilators for the management of acute exacerbations of chronic obstructive pulmonary disease in the hospital setting: systematic review
por: Kopsaftis, Zoe A., et al.
Publicado: (2018)

The Efficacy of Paroxetine and Placebo in Treating Anxiety and Depression: A Meta-Analysis of Change on the Hamilton Rating Scales
por: Sugarman, Michael A., et al.
Publicado: (2014)

Mixed Reality Technology to Deliver Psychological Interventions to Adolescents With Asthma: Qualitative Study Using the Theoretical Framework of Acceptability
por: Sharrad, Kelsey, et al.
Publicado: (2023)

Suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2005)

Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
por: Carson-Chahhoud, Kristin V., et al.
Publicado: (2020)

Paroxetine overdose
por: Gupta, Arun K., et al.
Publicado: (2005)

Even more suicide attempts in clinical trials with paroxetine randomised against placebo
por: Aursnes, Ivar, et al.
Publicado: (2006)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen, Jian-wei, et al.
Publicado: (2018)

Antidepressant and Neuroprotective Effects of 3-Hydroxy Paroxetine, an Analog of Paroxetine in Rats
por: Hernández-Arrambide, Pedro Efraín, et al.
Publicado: (2022)

Efficacy and tolerability of paroxetine in adults with social anxiety disorder: A meta-analysis of randomized controlled trials
por: Li, Xinyuan, et al.
Publicado: (2020)

Correction: Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial
por: Carson-Chahhoud, Kristin V., et al.
Publicado: (2021)

Paroxetine-induced galactorrhea
por: Gulati, Prannay, et al.
Publicado: (2014)

Paroxetine-induced galactorrhea
por: Petrykiv, S., et al.
Publicado: (2022)

Magnitude of placebo response in clinical trials of paroxetine for vasomotor symptoms: a meta-analysis
por: Rhodes, Joshua R., et al.
Publicado: (2023)

Short-Term Efficacy and Tolerability of Paroxetine Versus Placebo for Panic Disorder: A Meta-Analysis of Randomized Controlled Trials
por: Zhang, Beilin, et al.
Publicado: (2020)

Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
por: Moudi, Emadouddin, et al.
Publicado: (2016)

Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017)

Paroxetine overdose during pregnancy
por: Acar, Selin, et al.
Publicado: (2021)

Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019
por: Safiri, Saeid, et al.
Publicado: (2022)

Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
por: Carboni, Lucia, et al.
Publicado: (2019)

Tadalafil for veterans with chronic obstructive pulmonary disease—pulmonary hypertension: A multicenter, placebo‐controlled randomized trial
por: Maron, Bradley A., et al.
Publicado: (2022)

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex
por: Aree, Thammarat
Publicado: (2022)

PAC in FACTT: Time to PAC it in?
por: Mansour, Wissam, et al.
Publicado: (2008)

Effectiveness of paroxetine in the treatment of poststroke depression
por: Ma, Chen, et al.
Publicado: (2018)

Paroxetine combined with olanzapine in the treatment of schizophrenia
por: Wang, Ning, et al.
Publicado: (2020)

Paroxetine—Overview of the Molecular Mechanisms of Action
por: Kowalska, Magdalena, et al.
Publicado: (2021)

Parents as Agents of Change (PAC) in pediatric weight management: The protocol for the PAC randomized clinical trial
por: Ball, Geoff D C, et al.
Publicado: (2012)

Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing
por: Weeks, Janis C., et al.
Publicado: (2018)

Isn’t There an App for That? The Role of Smartphone and Tablet Applications for Asthma Education and Self-Management in Adolescents
por: O’Connor, Antonia, et al.
Publicado: (2021)

The Efficacy and Safety of On-demand Tramadol and Paroxetine Use in Treatment of Life Long Premature Ejaculation: A Randomized Double-blind Placebo-controlled Clinical Trial
por: Hamidi-Madani, Ali, et al.
Publicado: (2018)

Modified Suanzaorentang Had the Treatment Effect for Generalized Anxiety Disorder for the First 4 Weeks of Paroxetine Medication: A Pragmatic Randomized Controlled Study
por: Song, Ming-Fen, et al.
Publicado: (2017)

Effects of MK-7 Supplementation on Glycemic Status, Anthropometric Indices and Lipid Profile in Patients with Type 2 Diabetes: A Randomized Controlled Trial
por: Karamzad, Nahid, et al.
Publicado: (2020)

Combination of valproate and paroxetine in mice exposed to picrotoxin
por: Kamal, Sahar M
Publicado: (2012)

Paroxetine in the treatment of recurrent brief depressive disorder
por: Prakash, Sathya, et al.
Publicado: (2013)

Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
por: Singh, Manjeet, et al.
Publicado: (2015)

Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter
por: Davis, Bruce A., et al.
Publicado: (2016)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

Extra-Paramidal Side Effects Associated with Paroxetine
por: Nicholson, Simon D.
Publicado: (1992)

Successful Use of Risperidone, Trihexyphenidyl, and Paroxetine in Pregnancy
por: Goyal, Sandeep Kumar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4j1qeera9t868rmvavb1408tle